Autus Asset Management LLC Cuts Position in Monsanto Company (MON)

Autus Asset Management LLC decreased its holdings in Monsanto Company (NYSE:MON) by 42.8% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 3,468 shares of the basic materials company’s stock after selling 2,597 shares during the period. Autus Asset Management LLC’s holdings in Monsanto were worth $411,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of MON. Acrospire Investment Management LLC purchased a new position in Monsanto in the first quarter valued at approximately $113,000. Pinnacle Financial Partners Inc. purchased a new position in Monsanto in the second quarter valued at approximately $114,000. JNBA Financial Advisors raised its holdings in Monsanto by 3.9% in the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock valued at $135,000 after buying an additional 45 shares during the period. Armbruster Capital Management Inc. raised its holdings in Monsanto by 12.2% in the second quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock valued at $136,000 after buying an additional 125 shares during the period. Finally, Penserra Capital Management LLC grew its position in Monsanto by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,288 shares of the basic materials company’s stock valued at $145,000 after acquiring an additional 112 shares in the last quarter. Hedge funds and other institutional investors own 74.79% of the company’s stock.

Shares of Monsanto Company (MON) opened at 117.44 on Wednesday. Monsanto Company has a 1-year low of $97.35 and a 1-year high of $118.97. The firm has a 50-day moving average price of $117.21 and a 200-day moving average price of $116.36. The company has a market capitalization of $51.59 billion, a PE ratio of 25.37 and a beta of 1.07.

Monsanto (NYSE:MON) last announced its quarterly earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The firm had revenue of $4.23 billion for the quarter, compared to analysts’ expectations of $4.18 billion. During the same period in the prior year, the business posted $2.17 earnings per share. The business’s revenue was up 1.0% compared to the same quarter last year. Equities analysts anticipate that Monsanto Company will post $4.89 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be given a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 1.84%. The ex-dividend date is Thursday, October 5th. Monsanto’s dividend payout ratio (DPR) is 46.75%.

In other news, EVP Robert T. Fraley sold 52,410 shares of the stock in a transaction on Monday, July 10th. The stock was sold at an average price of $117.95, for a total transaction of $6,181,759.50. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Steven Mizell sold 11,300 shares of the stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total value of $1,339,841.00. Following the sale, the executive vice president now owns 55,011 shares in the company, valued at approximately $6,522,654.27. The disclosure for this sale can be found here. Corporate insiders own 0.79% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Autus Asset Management LLC Cuts Position in Monsanto Company (MON)” was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://sportsperspectives.com/2017/09/13/autus-asset-management-llc-cuts-position-in-monsanto-company-mon.html.

Several analysts have issued reports on MON shares. Zacks Investment Research raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price objective for the company in a research report on Friday, June 16th. Vetr raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price objective for the company in a research report on Wednesday, July 12th. Piper Jaffray Companies set a $128.00 price objective on shares of Monsanto and gave the company a “buy” rating in a research report on Friday, August 11th. BMO Capital Markets reaffirmed a “buy” rating and issued a $128.00 price objective on shares of Monsanto in a research report on Friday, September 1st. Finally, Barclays PLC increased their price objective on shares of Monsanto from $115.00 to $120.00 and gave the company an “equal weight” rating in a research report on Thursday, June 29th. One research analyst has rated the stock with a sell rating, eleven have given a hold rating and eight have issued a buy rating to the company’s stock. Monsanto currently has a consensus rating of “Hold” and a consensus target price of $123.43.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply